Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid infusion rate and postoperative nausea/vomiting after lumbar TLIF
ChiCTR2500110270Phase 4Not yet recruiting
- Sponsor
- West China Tianfu Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in lumbosacral disc disease (3 arms), sponsored by West China Tianfu Hospital. Primary endpoints: Nausea and Vomiting. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on ChiCTR2500110270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110270.